Single injection of autologous blood-derived product rich in DKK-1 protein, a Wnt pathway inhibitor, is clinically effective and safe in patients with osteoarthritis for up to 12 months

Saved in:
Bibliographic Details
Published in:Osteoarthritis and cartilage 2024-04, Vol.32, p.S306-S307
Main Authors: de Toro, Alberto V., Toledo Coello, Maria D., Madej, Wojciech
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1063-4584
DOI:10.1016/j.joca.2024.02.446